This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by MIYAKAWA, M. Articles by SHIZUME, K. Search for Related Content PubMed PubMed Citation Articles by MIYAKAWA, M. Articles by SHIZUME, K.

Thyroid Volume and Serum Thyroglobulin Levels in Patients with Acromegaly: Correlation with Plasma Insulin-Like Growth Factor I Levels^*

Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women’s Medical College, and the Institute for Growth Science Kawadacho 8-1 Shinjukuku, Tokyo 162 Japan

Address all correspondence and requests for reprints to: Dr. Megumi Miyakawa, Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women’s Medical College, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.

The pathogenesis of the goiter that is frequently found in patients with acromegaly is not known. Using ultrasonic scanning, we measured thyroid volume in 17 euthyroid patients with acromegaly and examined the relationships among thyroid size, plasma GH and insulin-like growth factor (IGF-I) levels, and serum thyroglobulin (TG) levels. The mean estimated thyroid volume in these 17 patients was 32.8 ± 15.5 (±SD) mL, significantly larger than that in normal subjects (15.4 ± 3.1 mL), and 64.7% of the patients had multinodular goiter, as identified by ultrasonography. Thyroid volume was positively correlated with plasma GH and IGF-I levels and heel-pad thickness, but not with the serum TSH level. In 7 patients, thyroid volume decreased in association with a decline in plasma GH and IGF-I levels after surgical treatment. The serum TG level was elevated in 7 of the 15 patients in whom it was measured, and the mean value was 51.7 ± 62.7 (±SD) µg/L (normal, 12.6 ± 6.4 µg/L). We found no correlations among the serum TG and TSH levels, plasma GH and IGF-I concentrations, and/or thyroid volume. However, serum TG decreased after surgical treatment, just as did plasma IGF-I. These observations together with the results of recent in vitro studies by others suggest that IGF-I is one of the factors involved in goiter formation, but the elevated serum TG levels in acromegaly are controlled not only by IGF-I but also by other factors.

^* This work was supported by grants from the Ministry of Health and Welfare and the Ministry of Education.

Received April 27, 1988.

This article has been cited by other articles:

				M. Scacchi, M. Andrioli, C. Carzaniga, G. Vitale, M. Moro, L. Poggi, F. Pecori Giraldi, L. M Fatti, and F. Cavagnini Elastosonographic evaluation of thyroid nodules in acromegaly Eur. J. Endocrinol., October 1, 2009; 161(4): 607 - 613. [Abstract] [Full Text] [PDF]

				M. Boas, L. Hegedus, U. Feldt-Rasmussen, N. E. Skakkebaek, L. Hilsted, and K. M. Main Association of Thyroid Gland Volume, Serum Insulin-Like Growth Factor-I, and Anthropometric Variables in Euthyroid Prepubertal Children J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 4031 - 4035. [Abstract] [Full Text] [PDF]

				T. Fukushima, T. Nedachi, H. Akizawa, M. Akahori, F. Hakuno, and S.-I. Takahashi Distinct Modes of Activation of Phosphatidylinositol 3-Kinase in Response to Cyclic Adenosine 3', 5'-Monophosphate or Insulin-Like Growth Factor I Play Different Roles in Regulation of Cyclin D1 and p27Kip1 in FRTL-5 Cells Endocrinology, July 1, 2008; 149(7): 3729 - 3742. [Abstract] [Full Text] [PDF]

				J. Wang, J. Grunler, and M. S. Lewitt Gender-Specific Pattern of Insulin-Like Growth Factor-Binding Protein-3 Protease Activity in Mouse Thyroid Endocrinology, March 1, 2004; 145(3): 1137 - 1143. [Abstract] [Full Text] [PDF]

				A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF]

				S. Clement, S. Refetoff, B. Robaye, J. E. Dumont, and S. Schurmans Low TSH Requirement and Goiter in Transgenic Mice Overexpressing IGF-I and IGF-I Receptor in the Thyroid Gland Endocrinology, December 1, 2001; 142(12): 5131 - 5139. [Abstract] [Full Text] [PDF]

				T. Kimura, A. Van Keymeulen, J. Golstein, A. Fusco, J. E. Dumont, and P. P. Roger Regulation of Thyroid Cell Proliferation by TSH and Other Factors: A Critical Evaluation of in Vitro Models Endocr. Rev., October 1, 2001; 22(5): 631 - 656. [Abstract] [Full Text] [PDF]

				Y. Fleury, G. Van Melle, V. Woringer, R. C. Gaillard, and L. Portmann Sex-Dependent Variations and Timing of Thyroid Growth during Puberty J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 750 - 754. [Abstract] [Full Text]

				P. Marzullo, A. Cuocolo, D. Ferone, R. Pivonello, M. Salvatore, G. Lombardi, and A. Colao Cardiac Effect of Thyrotoxicosis in Acromegaly J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1426 - 1432. [Abstract] [Full Text]

				T. Diamond, L. Nery, and S. Posen Spinal and Peripheral Bone Mineral Densities in Acromegaly: The Effects of Excess Growth Hormone and Hypogonadism Ann Intern Med, October 1, 1989; 111(7): 567 - 573. [Abstract] [PDF]